BEIJING SUCCEEDER TECHNOLOGY INC.

Daim ntawv pom zoo tseem ceeb thib plaub, uas tau coj los ntawm Pawg Neeg Saib Xyuas Thrombosis thiab Hemostasis ntawm Lub Koom Haum Tshawb Fawb Tuam Tshoj, tau raug tso tawm.

Daim ntawv "Kev Pom Zoo ntawm Cov Kws Tshaj Lij Txog Kev Saib Xyuas Kev Kho Mob ntawm Cov Tshuaj Heparin zoo li" tau tsim los ntawm Pawg Neeg Saib Xyuas Kev Ntshav thiab Kev Ntshav ntawm Lub Koom Haum Suav ntawm Cov Tsev Kho Mob Tshawb Fawb thiab Lub Chaw Tshawb Fawb Hauv Chaw Kuaj Mob ntawm Lub Koom Haum Neeg Laus ntawm Suav. Daim ntawv no, uas cov kws tshaj lij ntawm ntau lub koom haum thoob plaws Suav tau sau ua ke, siv sijhawm ob xyoos los tsim, tom qab ntau qhov kev sib tham thiab kev hloov kho. Daim ntawv kawg tau pom zoo thiab luam tawm thaum Lub Yim Hli 2025 hauv Phau Ntawv Xov Xwm Suav ntawm Kev Kho Mob Hauv Chaw Kuaj Mob, Ntim 48, Qhov Teeb Meem 8.

Qhov kev pom zoo no muab cov lus qhia txog kev soj ntsuam hauv chaw kuaj mob ntawm cov tshuaj zoo li heparin, muab kev txhawb nqa hauv chaw kuaj mob kom ntseeg tau dua rau kev siv tshuaj anticoagulant kom muaj kev nyab xeeb thiab ua tau zoo. Thaum kawg, nws yuav pab tau ntau tus neeg mob thiab ua rau kev kho mob heparin anticoagulant kom zoo dua qub thiab meej dua.

Cov Lus Qhia Tseem Ceeb

Cov tshuaj zoo li heparin feem ntau yog cov tshuaj anticoagulants rau kev tiv thaiv thiab kho cov kab mob thromboembolic. Kev siv kom raug thiab kev saib xyuas kom zoo ntawm cov tshuaj no yog qhov tseem ceeb rau kev ua kom muaj kev nyab xeeb thiab kev ua haujlwm zoo ntawm kev kho mob. Cov kws tshaj lij kev pom zoo no siv cov ntaub ntawv hauv tsev thiab thoob ntiaj teb, xav txog qhov xwm txheej tam sim no thiab kev nce qib ntawm kev siv heparin. Nws tau hu ib pawg kws tshaj lij hauv thaj chaw antithrombotic, suav nrog cov kws tshaj lij hauv chaw kuaj mob thiab chaw kho mob, los tham txog cov cim qhia, koob tshuaj, thiab kev saib xyuas ntawm heparin. Tshwj xeeb, nws tau piav qhia txog kev siv cov cim qhia hauv chaw kuaj mob xws li kev ua haujlwm anti-Xa thiab tsim cov lus pom zoo ntawm cov kws tshaj lij nrog lub hom phiaj ntawm kev txhawb nqa kev siv heparin kom muaj kev nyab xeeb thiab ua haujlwm zoo thiab ua kom muaj kev soj ntsuam hauv chaw kuaj mob.Tsab xov xwm no yog luam tawm dua los ntawm: Thrombosis thiab Hemostasis (CSTH).

Beijing Succeeder Technology Inc. (tus lej khoom lag luam: 688338) tau koom nrog tob hauv kev kuaj mob coagulation txij li thaum nws tau tsim tsa xyoo 2003, thiab tau cog lus tias yuav ua tus thawj coj hauv daim teb no. Lub tuam txhab muaj lub hauv paus nyob hauv Beijing, muaj pab pawg R&D, kev tsim khoom thiab kev muag khoom zoo, tsom mus rau kev tsim kho tshiab thiab kev siv cov thev naus laus zis kuaj mob thrombosis thiab hemostasis.

Nrog nws lub zog zoo tshaj plaws, Succeeder tau yeej 45 daim ntawv pov thawj patent, suav nrog 14 daim ntawv pov thawj tsim khoom, 16 daim ntawv pov thawj qauv siv hluav taws xob thiab 15 daim ntawv pov thawj tsim qauv. Lub tuam txhab kuj muaj 32 daim ntawv pov thawj sau npe khoom siv kho mob Class II, 3 daim ntawv pov thawj Class I, thiab daim ntawv pov thawj EU CE rau 14 yam khoom, thiab tau dhau daim ntawv pov thawj ISO 13485 kev tswj hwm zoo kom ntseeg tau tias qhov zoo tshaj plaws thiab ruaj khov ntawm cov khoom zoo.

Succeeder tsis yog tsuas yog ib lub tuam txhab tseem ceeb ntawm Beijing Biomedicine Industry Leapfrog Development Project (G20), tab sis kuj tau tsaws rau ntawm Science thiab Technology Innovation Board hauv xyoo 2020, ua tiav kev loj hlob ntawm lub tuam txhab. Tam sim no, lub tuam txhab tau tsim lub network muag khoom thoob plaws lub tebchaws uas npog ntau pua tus neeg sawv cev thiab chaw ua haujlwm. Nws cov khoom muag tau zoo hauv feem ntau ntawm lub tebchaws. Nws kuj tseem tab tom nthuav dav cov lag luam txawv teb chaws thiab txuas ntxiv txhim kho nws cov kev sib tw thoob ntiaj teb.